Research and Markets: Gene Therapy Metabolic Disorders Insights 2015 - Pipeline Assessment, Market Trend, Technology and Competitive Landscape

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/tkbxbw/gene_therapy) has announced the addition of the "Gene Therapy Metabolic Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape" report to their offering.

"Gene Therapy Metabolic Disorders Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Metabolic Disorders Report provides the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety DelveInsight Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.

"Gene Therapy Metabolic Disorders Report: Gene Therapy Metabolic Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape provides in depth insights into the Metabolic Disorders gene therapy. It has covered 30+ gene therapies covering 20+ Pharmaceutical companies. Studies are performed for approximately 30+ specific indications under Metabolic Disorders. The Companies are utilizing 16 different technology platforms which have its own uniqueness and robustness. The Report is also giving insights about the vectors usage in Gene therapy which is approximately 66% for viral vectors, 25% for RNAi therapeutics and 9% for Non Viral vectors.

Reports Highlights

- Global Gene Therapy Overview & Pipeline Insights

- Trends in gene therapy partnering deals

- Current Prominent Research Areas and Key Players

- Companies Targeting Prominent Therapeutic Areas

- Number of Gene Therapies in Clinical Trials

- Number of Gene Therapies by Vectors used

- Technology and their innovative Companies

- Early Market Winners for Gene Therapy

Scope

- A snapshot of the global Gene therapy market scenario, market trends & drivers, manacles of gene therapy.

- A review of the marketed Gene therapy products and marketing status

- Coverage of global gene therapies under development across the globe covering territories

- Competitive landscape of investigational products for key players and key therapy areas.

- The Gene Therapy report covers the product description, stage of development, licensors & collaborators, Development partner and Technology information

- The Report also provides the pre-clinical and clinical outcomes of the gene therapies

- The Report has covered the vector used, target genes, localization of gene and detailed mechanism of action

- Report has highlighted the licensing opportunities and funding details for gene therapies

- The report also gives the information of dormant and discontinued pipeline projects

For more information visit http://www.researchandmarkets.com/research/tkbxbw/gene_therapy

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals